JP2018510852A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018510852A5 JP2018510852A5 JP2017545627A JP2017545627A JP2018510852A5 JP 2018510852 A5 JP2018510852 A5 JP 2018510852A5 JP 2017545627 A JP2017545627 A JP 2017545627A JP 2017545627 A JP2017545627 A JP 2017545627A JP 2018510852 A5 JP2018510852 A5 JP 2018510852A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- unsubstituted
- aminomethyl
- pyridin
- oxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims description 25
- 150000003839 salts Chemical class 0.000 claims description 18
- -1 heterocyclic ring bicyclic compound Chemical class 0.000 claims description 11
- LIUIDMWKNRWMIS-UHFFFAOYSA-N 3-[4-(aminomethyl)pyridin-2-yl]-N-benzylbenzamide Chemical compound NCC1=CC(=NC=C1)C=1C=C(C(=O)NCC2=CC=CC=C2)C=CC=1 LIUIDMWKNRWMIS-UHFFFAOYSA-N 0.000 claims description 3
- LLRXFUQAAZQTBR-UHFFFAOYSA-N 3-[4-(aminomethyl)pyridin-2-yl]oxy-N-(2,4-difluorophenyl)benzamide Chemical compound NCC1=CC(=NC=C1)OC=1C=C(C(=O)NC2=C(C=C(C=C2)F)F)C=CC=1 LLRXFUQAAZQTBR-UHFFFAOYSA-N 0.000 claims description 3
- IIJOUPDJYSTSBW-UHFFFAOYSA-N 3-[4-(aminomethyl)pyridin-2-yl]oxy-N-(3-methoxyphenyl)benzamide Chemical compound NCC1=CC(=NC=C1)OC=1C=C(C(=O)NC2=CC(=CC=C2)OC)C=CC=1 IIJOUPDJYSTSBW-UHFFFAOYSA-N 0.000 claims description 3
- KKSAXTCEFKJMEZ-UHFFFAOYSA-N 3-[4-(aminomethyl)pyridin-2-yl]oxy-N-(4-methoxyphenyl)benzamide Chemical compound NCC1=CC(=NC=C1)OC=1C=C(C(=O)NC2=CC=C(C=C2)OC)C=CC=1 KKSAXTCEFKJMEZ-UHFFFAOYSA-N 0.000 claims description 3
- ZOGOKEYUMAJDEO-UHFFFAOYSA-N 3-[4-(aminomethyl)pyridin-2-yl]oxy-N-[3-(trifluoromethyl)phenyl]benzamide Chemical compound NCC1=CC(=NC=C1)OC=1C=C(C(=O)NC2=CC(=CC=C2)C(F)(F)F)C=CC=1 ZOGOKEYUMAJDEO-UHFFFAOYSA-N 0.000 claims description 3
- XGRLLLJVGNTYSK-UHFFFAOYSA-N 3-[4-(aminomethyl)pyridin-2-yl]oxy-N-tridecylbenzamide Chemical compound NCC1=CC(=NC=C1)OC=1C=C(C(=O)NCCCCCCCCCCCCC)C=CC=1 XGRLLLJVGNTYSK-UHFFFAOYSA-N 0.000 claims description 3
- CIBGXOAZCPUGAU-UHFFFAOYSA-N 4-[4-(aminomethyl)pyridin-2-yl]-N-phenylbenzamide Chemical compound NCC1=CC(=NC=C1)C1=CC=C(C(=O)NC2=CC=CC=C2)C=C1 CIBGXOAZCPUGAU-UHFFFAOYSA-N 0.000 claims description 3
- CKJNUZNMWOVDFN-UHFFFAOYSA-N methanone Chemical compound O=[CH-] CKJNUZNMWOVDFN-UHFFFAOYSA-N 0.000 claims description 3
- KQALDCNFWKKTOY-UHFFFAOYSA-N 3-[4-(aminomethyl)pyridin-2-yl]-N-(2-methoxyethyl)benzamide Chemical compound NCC1=CC(=NC=C1)C=1C=C(C(=O)NCCOC)C=CC=1 KQALDCNFWKKTOY-UHFFFAOYSA-N 0.000 claims description 2
- FJYDBKYVCJLPTH-UHFFFAOYSA-N 3-[4-(aminomethyl)pyridin-2-yl]-N-(5-chloro-2-methylphenyl)benzamide Chemical compound NCC1=CC(=NC=C1)C=1C=C(C(=O)NC2=C(C=CC(=C2)Cl)C)C=CC=1 FJYDBKYVCJLPTH-UHFFFAOYSA-N 0.000 claims description 2
- ABFLLPKYLYQDMD-UHFFFAOYSA-N 3-[4-(aminomethyl)pyridin-2-yl]-N-(6-chloro-1H-indol-4-yl)benzamide Chemical compound NCC1=CC(=NC=C1)C=1C=C(C(=O)NC2=C3C=CNC3=CC(=C2)Cl)C=CC=1 ABFLLPKYLYQDMD-UHFFFAOYSA-N 0.000 claims description 2
- GTRIVUDDNMZGDQ-UHFFFAOYSA-N 3-[4-(aminomethyl)pyridin-2-yl]-N-phenylbenzamide Chemical compound NCC1=CC(=NC=C1)C=1C=C(C(=O)NC2=CC=CC=C2)C=CC=1 GTRIVUDDNMZGDQ-UHFFFAOYSA-N 0.000 claims description 2
- HZOSNBJSMRCDMY-UHFFFAOYSA-N 3-[4-(aminomethyl)pyridin-2-yl]oxy-N-(1-benzothiophen-2-ylmethyl)benzamide Chemical compound NCC1=CC(=NC=C1)OC=1C=C(C(=O)NCC2=CC3=C(S2)C=CC=C3)C=CC=1 HZOSNBJSMRCDMY-UHFFFAOYSA-N 0.000 claims description 2
- IUMJMWGBIFYVAC-UHFFFAOYSA-N 3-[4-(aminomethyl)pyridin-2-yl]oxy-N-(2-methoxyethyl)benzamide Chemical compound NCC1=CC(=NC=C1)OC=1C=C(C(=O)NCCOC)C=CC=1 IUMJMWGBIFYVAC-UHFFFAOYSA-N 0.000 claims description 2
- WKJSUDSRVONOIH-UHFFFAOYSA-N 3-[4-(aminomethyl)pyridin-2-yl]oxy-N-(2-phenylethyl)benzamide Chemical compound NCC1=CC(=NC=C1)OC=1C=C(C(=O)NCCC2=CC=CC=C2)C=CC=1 WKJSUDSRVONOIH-UHFFFAOYSA-N 0.000 claims description 2
- BFTRSRQMNCXYRT-UHFFFAOYSA-N 3-[4-(aminomethyl)pyridin-2-yl]oxy-N-(4-bromophenyl)benzamide Chemical compound NCC1=CC(=NC=C1)OC=1C=C(C(=O)NC2=CC=C(C=C2)Br)C=CC=1 BFTRSRQMNCXYRT-UHFFFAOYSA-N 0.000 claims description 2
- RPTMISIWMXZWAU-UHFFFAOYSA-N 3-[4-(aminomethyl)pyridin-2-yl]oxy-N-(4-fluorophenyl)benzamide Chemical compound NCC1=CC(=NC=C1)OC=1C=C(C(=O)NC2=CC=C(C=C2)F)C=CC=1 RPTMISIWMXZWAU-UHFFFAOYSA-N 0.000 claims description 2
- QVNMODWDNBHNGS-UHFFFAOYSA-N 3-[4-(aminomethyl)pyridin-2-yl]oxy-N-(pyrazin-2-ylmethyl)benzamide Chemical compound NCC1=CC(=NC=C1)OC=1C=C(C(=O)NCC2=NC=CN=C2)C=CC=1 QVNMODWDNBHNGS-UHFFFAOYSA-N 0.000 claims description 2
- BKJHKBNJSCIQOY-IBGZPJMESA-N 3-[4-(aminomethyl)pyridin-2-yl]oxy-N-[(1R)-2-hydroxy-1-phenylethyl]benzamide Chemical compound NCC1=CC(=NC=C1)OC=1C=C(C(=O)N[C@@H](CO)C2=CC=CC=C2)C=CC=1 BKJHKBNJSCIQOY-IBGZPJMESA-N 0.000 claims description 2
- BHKAZBAZIKMOGM-UHFFFAOYSA-N 3-[4-(aminomethyl)pyridin-2-yl]oxy-N-[(2,4-difluorophenyl)methyl]benzamide Chemical compound NCC1=CC(=NC=C1)OC=1C=C(C(=O)NCC2=C(C=C(C=C2)F)F)C=CC=1 BHKAZBAZIKMOGM-UHFFFAOYSA-N 0.000 claims description 2
- YWVZYIAESUQULQ-UHFFFAOYSA-N 3-[4-(aminomethyl)pyridin-2-yl]oxy-N-[(3-carbamimidoylphenyl)methyl]benzamide Chemical compound NCC1=CC(=NC=C1)OC=1C=C(C(=O)NCC2=CC(=CC=C2)C(N)=N)C=CC=1 YWVZYIAESUQULQ-UHFFFAOYSA-N 0.000 claims description 2
- HEURIQPAZZQVGE-UHFFFAOYSA-N 3-[4-(aminomethyl)pyridin-2-yl]oxy-N-[(3-fluoro-4-imidazol-1-ylphenyl)methyl]benzamide Chemical compound NCC1=CC(=NC=C1)OC=1C=C(C(=O)NCC2=CC(=C(C=C2)N2C=NC=C2)F)C=CC=1 HEURIQPAZZQVGE-UHFFFAOYSA-N 0.000 claims description 2
- HOLNIDQMPCIVFH-UHFFFAOYSA-N 3-[4-(aminomethyl)pyridin-2-yl]oxy-N-[(4-bromophenyl)methyl]benzamide Chemical compound NCC1=CC(=NC=C1)OC=1C=C(C(=O)NCC2=CC=C(C=C2)Br)C=CC=1 HOLNIDQMPCIVFH-UHFFFAOYSA-N 0.000 claims description 2
- ZRUBRPSILIFDQG-UHFFFAOYSA-N 3-[4-(aminomethyl)pyridin-2-yl]oxy-N-[4-(trifluoromethyl)phenyl]benzamide Chemical compound NCC1=CC(=NC=C1)OC=1C=C(C(=O)NC2=CC=C(C=C2)C(F)(F)F)C=CC=1 ZRUBRPSILIFDQG-UHFFFAOYSA-N 0.000 claims description 2
- OVEOBZPMHITBIB-UHFFFAOYSA-N 3-[4-(aminomethyl)pyridin-2-yl]oxy-N-[[4-(4-ethylpiperazin-1-yl)phenyl]methyl]benzamide Chemical compound NCC1=CC(=NC=C1)OC=1C=C(C(=O)NCC2=CC=C(C=C2)N2CCN(CC2)CC)C=CC=1 OVEOBZPMHITBIB-UHFFFAOYSA-N 0.000 claims description 2
- HGMGTTVDCACMDN-UHFFFAOYSA-N 3-[4-(aminomethyl)pyridin-2-yl]oxy-N-[[4-(trifluoromethyl)phenyl]methyl]benzamide Chemical compound NCC1=CC(=NC=C1)OC=1C=C(C(=O)NCC2=CC=C(C=C2)C(F)(F)F)C=CC=1 HGMGTTVDCACMDN-UHFFFAOYSA-N 0.000 claims description 2
- FQVUWJYJPDWXIX-UHFFFAOYSA-N 3-[4-(aminomethyl)pyridin-2-yl]oxy-N-benzylbenzamide Chemical compound NCC1=CC(=NC=C1)OC=1C=C(C(=O)NCC2=CC=CC=C2)C=CC=1 FQVUWJYJPDWXIX-UHFFFAOYSA-N 0.000 claims description 2
- HWQXLDSAJUNZAU-UHFFFAOYSA-N 3-[4-(aminomethyl)pyridin-2-yl]oxy-N-phenylbenzamide Chemical compound NCC1=CC(=NC=C1)OC=1C=C(C(=O)NC2=CC=CC=C2)C=CC=1 HWQXLDSAJUNZAU-UHFFFAOYSA-N 0.000 claims description 2
- OQYGDEPLJLNFQD-UHFFFAOYSA-N 3-[[3-[4-(aminomethyl)pyridin-2-yl]oxybenzoyl]amino]benzoic acid Chemical compound NCC1=CC(=NC=C1)OC=1C=C(C(=O)NC=2C=C(C(=O)O)C=CC=2)C=CC=1 OQYGDEPLJLNFQD-UHFFFAOYSA-N 0.000 claims description 2
- KNHQKWFHWLBNHO-UHFFFAOYSA-N 3-[[4-(aminomethyl)pyridin-2-yl]oxymethyl]-N-phenylbenzamide Chemical compound NCC1=CC(=NC=C1)OCC=1C=C(C(=O)NC2=CC=CC=C2)C=CC=1 KNHQKWFHWLBNHO-UHFFFAOYSA-N 0.000 claims description 2
- TXWRMUOPZRZXAR-UHFFFAOYSA-N 3-[[[3-[4-(aminomethyl)pyridin-2-yl]oxybenzoyl]amino]methyl]benzoic acid Chemical compound NCC1=CC(=NC=C1)OC=1C=C(C(=O)NCC=2C=C(C(=O)O)C=CC=2)C=CC=1 TXWRMUOPZRZXAR-UHFFFAOYSA-N 0.000 claims description 2
- UCWMLEPMQKZORS-UHFFFAOYSA-N 4-[4-(aminomethyl)pyridin-2-yl]-N-(2-methoxyethyl)benzamide Chemical compound NCC1=CC(=NC=C1)C1=CC=C(C(=O)NCCOC)C=C1 UCWMLEPMQKZORS-UHFFFAOYSA-N 0.000 claims description 2
- DXQWWEUVIGNTOY-UHFFFAOYSA-N 4-[4-(aminomethyl)pyridin-2-yl]-N-benzylbenzamide Chemical compound NCC1=CC(=NC=C1)C1=CC=C(C(=O)NCC2=CC=CC=C2)C=C1 DXQWWEUVIGNTOY-UHFFFAOYSA-N 0.000 claims description 2
- HOUYIBMMOZYANR-UHFFFAOYSA-N 4-[4-(aminomethyl)pyridin-2-yl]oxy-N-(2-methoxyethyl)benzamide Chemical compound NCC1=CC(=NC=C1)OC1=CC=C(C(=O)NCCOC)C=C1 HOUYIBMMOZYANR-UHFFFAOYSA-N 0.000 claims description 2
- PVUHBMXOIZKNHK-UHFFFAOYSA-N 4-[4-(aminomethyl)pyridin-2-yl]oxy-N-benzylbenzamide Chemical compound NCC1=CC(=NC=C1)OC1=CC=C(C(=O)NCC2=CC=CC=C2)C=C1 PVUHBMXOIZKNHK-UHFFFAOYSA-N 0.000 claims description 2
- MMVQJHXOWFTQPV-UHFFFAOYSA-N 4-[4-(aminomethyl)pyridin-2-yl]oxy-N-phenylbenzamide Chemical compound NCC1=CC(=NC=C1)OC1=CC=C(C(=O)NC2=CC=CC=C2)C=C1 MMVQJHXOWFTQPV-UHFFFAOYSA-N 0.000 claims description 2
- ICUFXLHEFRTNQM-UHFFFAOYSA-N 4-[[3-[4-(aminomethyl)pyridin-2-yl]oxybenzoyl]amino]benzoic acid Chemical compound NCC1=CC(=NC=C1)OC=1C=C(C(=O)NC2=CC=C(C(=O)O)C=C2)C=CC=1 ICUFXLHEFRTNQM-UHFFFAOYSA-N 0.000 claims description 2
- XQFUMTQVTHNHFH-UHFFFAOYSA-N 4-[[[3-[4-(aminomethyl)pyridin-2-yl]oxybenzoyl]amino]methyl]benzoic acid Chemical compound NCC1=CC(=NC=C1)OC=1C=C(C(=O)NCC2=CC=C(C(=O)O)C=C2)C=CC=1 XQFUMTQVTHNHFH-UHFFFAOYSA-N 0.000 claims description 2
- MAPGRQSVGRBDGP-UHFFFAOYSA-N [3-[4-(aminomethyl)pyridin-2-yl]oxyphenyl]-(3,4-dihydro-1H-isoquinolin-2-yl)methanone Chemical compound NCC1=CC(=NC=C1)OC=1C=C(C=CC=1)C(=O)N1CC2=CC=CC=C2CC1 MAPGRQSVGRBDGP-UHFFFAOYSA-N 0.000 claims description 2
- SKHNNUXTQYYXJG-UHFFFAOYSA-N ethyl 3-[[3-[4-(aminomethyl)pyridin-2-yl]oxybenzoyl]amino]benzoate Chemical compound NCC1=CC(=NC=C1)OC=1C=C(C(=O)NC=2C=C(C(=O)OCC)C=CC=2)C=CC=1 SKHNNUXTQYYXJG-UHFFFAOYSA-N 0.000 claims description 2
- RSIVXCHSEZQCQY-UHFFFAOYSA-N methyl 4-[[[3-[4-(aminomethyl)pyridin-2-yl]oxybenzoyl]amino]methyl]benzoate Chemical compound NCC1=CC(=NC=C1)OC=1C=C(C(=O)NCC2=CC=C(C(=O)OC)C=C2)C=CC=1 RSIVXCHSEZQCQY-UHFFFAOYSA-N 0.000 claims description 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 11
- 125000000623 heterocyclic group Chemical group 0.000 claims 10
- 125000003118 aryl group Chemical group 0.000 claims 9
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 8
- 125000002733 (C1-C6) fluoroalkyl group Chemical group 0.000 claims 7
- 125000006716 (C1-C6) heteroalkyl group Chemical group 0.000 claims 6
- 125000002619 bicyclic group Chemical group 0.000 claims 6
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 6
- 229910052739 hydrogen Inorganic materials 0.000 claims 6
- 125000006747 (C2-C10) heterocycloalkyl group Chemical group 0.000 claims 5
- 125000000753 cycloalkyl group Chemical group 0.000 claims 5
- 229910052799 carbon Inorganic materials 0.000 claims 4
- 229910052805 deuterium Inorganic materials 0.000 claims 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 4
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 3
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 3
- 229910052736 halogen Inorganic materials 0.000 claims 3
- 150000002367 halogens Chemical class 0.000 claims 3
- 125000002950 monocyclic group Chemical group 0.000 claims 3
- 125000002618 bicyclic heterocycle group Chemical group 0.000 claims 2
- 150000001721 carbon Chemical group 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 125000004430 oxygen atom Chemical group O* 0.000 claims 2
- 125000004434 sulfur atom Chemical group 0.000 claims 2
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 claims 1
- 125000004605 1,2,3,4-tetrahydroisoquinolinyl group Chemical group C1(NCCC2=CC=CC=C12)* 0.000 claims 1
- 125000004607 1,2,3,4-tetrahydroquinolinyl group Chemical group N1(CCCC2=CC=CC=C12)* 0.000 claims 1
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 claims 1
- GFYVLORSTQYVPF-UHFFFAOYSA-N 4-[4-(aminomethyl)pyridin-2-yl]oxy-N-phenylindole-1-carboxamide Chemical compound NCC1=CC(=NC=C1)OC1=C2C=CN(C2=CC=C1)C(=O)NC1=CC=CC=C1 GFYVLORSTQYVPF-UHFFFAOYSA-N 0.000 claims 1
- 206010016654 Fibrosis Diseases 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- KGUABBMSFFEWGS-UHFFFAOYSA-N [4-[4-(aminomethyl)pyridin-2-yl]oxyindol-1-yl]-phenylmethanone Chemical compound NCC1=CC(=NC=C1)OC1=C2C=CN(C2=CC=C1)C(=O)C1=CC=CC=C1 KGUABBMSFFEWGS-UHFFFAOYSA-N 0.000 claims 1
- 125000002947 alkylene group Chemical group 0.000 claims 1
- 125000002393 azetidinyl group Chemical group 0.000 claims 1
- 125000004069 aziridinyl group Chemical group 0.000 claims 1
- 125000002527 bicyclic carbocyclic group Chemical group 0.000 claims 1
- 229910052794 bromium Inorganic materials 0.000 claims 1
- 125000002837 carbocyclic group Chemical group 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000004761 fibrosis Effects 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 claims 1
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 claims 1
- 125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000002757 morpholinyl group Chemical group 0.000 claims 1
- 125000001624 naphthyl group Chemical group 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 125000004193 piperazinyl group Chemical group 0.000 claims 1
- 125000003386 piperidinyl group Chemical group 0.000 claims 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 125000001712 tetrahydronaphthyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 claims 1
- 125000004568 thiomorpholinyl group Chemical group 0.000 claims 1
- SONNQRNOTIAJDS-GFCCVEGCSA-N 3-[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxy-N-[(2R)-2,3-dihydroxypropyl]benzamide Chemical compound NCC1=CC(=NC(=C1)C(F)(F)F)OC=1C=C(C(=O)NC[C@H](CO)O)C=CC=1 SONNQRNOTIAJDS-GFCCVEGCSA-N 0.000 description 2
- NRLQBVLOUUPAMI-UHFFFAOYSA-N 8-[3-[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxybenzoyl]-1-oxa-3,8-diazaspiro[4.5]decan-2-one Chemical compound NCC1=CC(=NC(=C1)C(F)(F)F)OC=1C=C(C(=O)N2CCC3(CNC(O3)=O)CC2)C=CC=1 NRLQBVLOUUPAMI-UHFFFAOYSA-N 0.000 description 2
- JOSCNYCOYXTLTN-GFCCVEGCSA-N [3-[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxyphenyl]-[(3R)-3-(hydroxymethyl)pyrrolidin-1-yl]methanone Chemical compound NCC1=CC(=NC(=C1)C(F)(F)F)OC=1C=C(C=CC=1)C(=O)N1C[C@@H](CC1)CO JOSCNYCOYXTLTN-GFCCVEGCSA-N 0.000 description 2
- VJLYHTOSFSGXGH-CQSZACIVSA-N (2R)-1-[3-[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxybenzoyl]pyrrolidine-2-carboxylic acid Chemical compound NCC1=CC(=NC(=C1)C(F)(F)F)OC=1C=C(C(=O)N2[C@H](CCC2)C(=O)O)C=CC=1 VJLYHTOSFSGXGH-CQSZACIVSA-N 0.000 description 1
- ZXAQFYZQHPGMMN-BZSJEYESSA-N (3R)-3-[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxy-N-phenylcyclohexane-1-carboxamide Chemical compound C1C[C@H](CC(C1)C(=O)NC2=CC=CC=C2)OC3=CC(=CC(=N3)C(F)(F)F)CN ZXAQFYZQHPGMMN-BZSJEYESSA-N 0.000 description 1
- ZWHOTPNCEFWATE-CQSZACIVSA-N (3R)-3-[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxy-N-phenylpyrrolidine-1-carboxamide Chemical compound NCC1=CC(=NC(=C1)C(F)(F)F)O[C@H]1CN(CC1)C(=O)NC1=CC=CC=C1 ZWHOTPNCEFWATE-CQSZACIVSA-N 0.000 description 1
- ZWHOTPNCEFWATE-AWEZNQCLSA-N (3S)-3-[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxy-N-phenylpyrrolidine-1-carboxamide Chemical compound NCC1=CC(=NC(=C1)C(F)(F)F)O[C@@H]1CN(CC1)C(=O)NC1=CC=CC=C1 ZWHOTPNCEFWATE-AWEZNQCLSA-N 0.000 description 1
- SNAKUPLQASYKTC-AWEZNQCLSA-N (3S)-3-[[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxymethyl]-N-phenylpiperidine-1-carboxamide Chemical compound NCC1=CC(=NC(=C1)C(F)(F)F)OC[C@@H]1CN(CCC1)C(=O)NC1=CC=CC=C1 SNAKUPLQASYKTC-AWEZNQCLSA-N 0.000 description 1
- BVKRPQCDGACLPX-UHFFFAOYSA-N 2-[4-[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxyindol-1-yl]-N-methyl-N-phenylacetamide Chemical compound NCC1=CC(=NC(=C1)C(F)(F)F)OC1=C2C=CN(C2=CC=C1)CC(=O)N(C1=CC=CC=C1)C BVKRPQCDGACLPX-UHFFFAOYSA-N 0.000 description 1
- WSNKEJIFARPOSQ-UHFFFAOYSA-N 3-[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxy-N-(1-benzothiophen-2-ylmethyl)benzamide Chemical compound NCC1=CC(=NC(=C1)C(F)(F)F)OC=1C=C(C(=O)NCC2=CC3=C(S2)C=CC=C3)C=CC=1 WSNKEJIFARPOSQ-UHFFFAOYSA-N 0.000 description 1
- CJYDQTAWSHWBIT-UHFFFAOYSA-N 3-[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxy-N-(2-hydroxy-2-methylpropyl)benzamide Chemical compound NCC1=CC(=NC(=C1)C(F)(F)F)OC=1C=C(C(=O)NCC(C)(C)O)C=CC=1 CJYDQTAWSHWBIT-UHFFFAOYSA-N 0.000 description 1
- MROVZCRMXJZHCN-UHFFFAOYSA-N 3-[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxy-N-(2-hydroxyethyl)benzamide Chemical compound NCC1=CC(=NC(=C1)C(F)(F)F)OC=1C=C(C(=O)NCCO)C=CC=1 MROVZCRMXJZHCN-UHFFFAOYSA-N 0.000 description 1
- SHBHYINHXNTBRP-UHFFFAOYSA-N 3-[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxy-N-(2-methylsulfonylethyl)benzamide Chemical compound NCC1=CC(=NC(=C1)C(F)(F)F)OC=1C=C(C(=O)NCCS(=O)(=O)C)C=CC=1 SHBHYINHXNTBRP-UHFFFAOYSA-N 0.000 description 1
- LIDBMZYKSAXTQG-UHFFFAOYSA-N 3-[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxy-N-(2-sulfamoylethyl)benzamide Chemical compound NCC1=CC(=NC(=C1)C(F)(F)F)OC=1C=C(C(=O)NCCS(N)(=O)=O)C=CC=1 LIDBMZYKSAXTQG-UHFFFAOYSA-N 0.000 description 1
- VTNULXUEOJMRKZ-UHFFFAOYSA-N 3-[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxy-N-(2H-tetrazol-5-ylmethyl)benzamide Chemical compound N=1NN=NC=1CNC(C1=CC(=CC=C1)OC1=NC(=CC(=C1)CN)C(F)(F)F)=O VTNULXUEOJMRKZ-UHFFFAOYSA-N 0.000 description 1
- GDSLUYKCPYECNN-UHFFFAOYSA-N 3-[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxy-N-[(4-fluorophenyl)methyl]benzamide Chemical compound NCC1=CC(=NC(=C1)C(F)(F)F)OC=1C=C(C(=O)NCC2=CC=C(C=C2)F)C=CC=1 GDSLUYKCPYECNN-UHFFFAOYSA-N 0.000 description 1
- ISXSUKUXUPLGTD-UHFFFAOYSA-N 3-[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxy-N-[(5-oxopyrrolidin-2-yl)methyl]benzamide Chemical compound NCC1=CC(=NC(=C1)C(F)(F)F)OC=1C=C(C(=O)NCC2NC(CC2)=O)C=CC=1 ISXSUKUXUPLGTD-UHFFFAOYSA-N 0.000 description 1
- FJPUKTJEFOXMJX-UHFFFAOYSA-N 3-[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxy-N-[1-(hydroxymethyl)cyclopropyl]benzamide Chemical compound NCC1=CC(=NC(=C1)C(F)(F)F)OC=1C=C(C(=O)NC2(CC2)CO)C=CC=1 FJPUKTJEFOXMJX-UHFFFAOYSA-N 0.000 description 1
- ZMCQQCBOZIGNRV-UHFFFAOYSA-N 3-[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxy-N-[2-(1,2,4-triazol-1-yl)ethyl]benzamide Chemical compound NCC1=CC(OC2=CC=CC(=C2)C(=O)NCCN2C=NC=N2)=NC(=C1)C(F)(F)F ZMCQQCBOZIGNRV-UHFFFAOYSA-N 0.000 description 1
- FVQKGQNSCKJPIJ-UHFFFAOYSA-N 3-[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxy-N-[2-(2-oxo-1,3-oxazolidin-3-yl)ethyl]benzamide Chemical compound NCC1=CC(=NC(=C1)C(F)(F)F)OC=1C=C(C(=O)NCCN2C(OCC2)=O)C=CC=1 FVQKGQNSCKJPIJ-UHFFFAOYSA-N 0.000 description 1
- ZUNFPBNHELLPPP-UHFFFAOYSA-N 3-[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxy-N-[2-(dimethylamino)ethyl]benzamide Chemical compound NCC1=CC(=NC(=C1)C(F)(F)F)OC=1C=C(C(=O)NCCN(C)C)C=CC=1 ZUNFPBNHELLPPP-UHFFFAOYSA-N 0.000 description 1
- AJZDHLHTTJRNQJ-UHFFFAOYSA-N 3-[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxy-N-[2-(tetrazol-1-yl)ethyl]benzamide Chemical compound N1(N=NN=C1)CCNC(C1=CC(=CC=C1)OC1=NC(=CC(=C1)CN)C(F)(F)F)=O AJZDHLHTTJRNQJ-UHFFFAOYSA-N 0.000 description 1
- MZSAMHOCTRNOIZ-UHFFFAOYSA-N 3-[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxy-N-phenylaniline Chemical compound NCC1=CC(=NC(=C1)C(F)(F)F)OC=1C=C(NC2=CC=CC=C2)C=CC=1 MZSAMHOCTRNOIZ-UHFFFAOYSA-N 0.000 description 1
- HAEQAUJYNHQVHV-UHFFFAOYSA-N 3-[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxy-N-phenylbenzamide Chemical compound NCC1=CC(=NC(=C1)C(F)(F)F)OC=1C=C(C(=O)NC2=CC=CC=C2)C=CC=1 HAEQAUJYNHQVHV-UHFFFAOYSA-N 0.000 description 1
- QEIVWSRXBYOTAZ-UHFFFAOYSA-N 4-[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxy-N-phenylpiperidine-1-carboxamide Chemical compound NCC1=CC(=NC(=C1)C(F)(F)F)OC1CCN(CC1)C(=O)NC1=CC=CC=C1 QEIVWSRXBYOTAZ-UHFFFAOYSA-N 0.000 description 1
- HOWFLZVASJDZRZ-UHFFFAOYSA-N 4-[[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxymethyl]-N-phenylpiperidine-1-carboxamide Chemical compound NCC1=CC(=NC(=C1)C(F)(F)F)OCC1CCN(CC1)C(=O)NC1=CC=CC=C1 HOWFLZVASJDZRZ-UHFFFAOYSA-N 0.000 description 1
- ZEEBGORNQSEQBE-UHFFFAOYSA-N [2-(3-phenylphenoxy)-6-(trifluoromethyl)pyridin-4-yl]methanamine Chemical compound C1(=CC(=CC=C1)OC1=NC(=CC(=C1)CN)C(F)(F)F)C1=CC=CC=C1 ZEEBGORNQSEQBE-UHFFFAOYSA-N 0.000 description 1
- GXFIJNNOECYQOJ-UHFFFAOYSA-N [2-[1-(1-methylpyrazol-4-yl)indol-4-yl]oxy-6-(trifluoromethyl)pyridin-4-yl]methanamine Chemical compound CN1N=CC(=C1)N1C=CC2=C(C=CC=C12)OC1=NC(=CC(=C1)CN)C(F)(F)F GXFIJNNOECYQOJ-UHFFFAOYSA-N 0.000 description 1
- REAYFGLASQTHKB-UHFFFAOYSA-N [2-[3-(1H-pyrazol-4-yl)phenoxy]-6-(trifluoromethyl)pyridin-4-yl]methanamine Chemical compound N1N=CC(=C1)C=1C=C(OC2=NC(=CC(=C2)CN)C(F)(F)F)C=CC=1 REAYFGLASQTHKB-UHFFFAOYSA-N 0.000 description 1
- SAHIZENKTPRYSN-UHFFFAOYSA-N [2-[3-(phenoxymethyl)phenoxy]-6-(trifluoromethyl)pyridin-4-yl]methanamine Chemical compound O(C1=CC=CC=C1)CC=1C=C(OC2=NC(=CC(=C2)CN)C(F)(F)F)C=CC=1 SAHIZENKTPRYSN-UHFFFAOYSA-N 0.000 description 1
- ABRVLXLNVJHDRQ-UHFFFAOYSA-N [2-pyridin-3-yl-6-(trifluoromethyl)pyridin-4-yl]methanamine Chemical compound FC(C1=CC(=CC(=N1)C=1C=NC=CC=1)CN)(F)F ABRVLXLNVJHDRQ-UHFFFAOYSA-N 0.000 description 1
- YQYBUJYBXOVWQW-UHFFFAOYSA-N [3-[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxyphenyl]-(3,4-dihydro-1H-isoquinolin-2-yl)methanone Chemical compound NCC1=CC(=NC(=C1)C(F)(F)F)OC=1C=C(C=CC=1)C(=O)N1CC2=CC=CC=C2CC1 YQYBUJYBXOVWQW-UHFFFAOYSA-N 0.000 description 1
- YKKPYMXANSSQCA-UHFFFAOYSA-N [3-[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxyphenyl]-(3-pyrazol-1-ylazetidin-1-yl)methanone Chemical compound N1(N=CC=C1)C1CN(C1)C(=O)C1=CC(=CC=C1)OC1=NC(=CC(=C1)CN)C(F)(F)F YKKPYMXANSSQCA-UHFFFAOYSA-N 0.000 description 1
- BYWBCSRCPLBDFU-CYBMUJFWSA-N [3-[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxyphenyl]-[(3R)-3-aminopyrrolidin-1-yl]methanone Chemical compound NCC1=CC(=NC(=C1)C(F)(F)F)OC=1C=C(C=CC=1)C(=O)N1C[C@@H](CC1)N BYWBCSRCPLBDFU-CYBMUJFWSA-N 0.000 description 1
- LJHFUFVRZNYVMK-CYBMUJFWSA-N [3-[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxyphenyl]-[(3R)-3-hydroxypyrrolidin-1-yl]methanone Chemical compound NCC1=CC(=NC(=C1)C(F)(F)F)OC=1C=C(C=CC=1)C(=O)N1C[C@@H](CC1)O LJHFUFVRZNYVMK-CYBMUJFWSA-N 0.000 description 1
- LJHFUFVRZNYVMK-ZDUSSCGKSA-N [3-[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxyphenyl]-[(3S)-3-hydroxypyrrolidin-1-yl]methanone Chemical compound NCC1=CC(=NC(=C1)C(F)(F)F)OC=1C=C(C=CC=1)C(=O)N1C[C@H](CC1)O LJHFUFVRZNYVMK-ZDUSSCGKSA-N 0.000 description 1
- JWSIZPAOIFLWKM-UHFFFAOYSA-N [3-[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxyphenyl]-[3-(dimethylamino)-4-hydroxypyrrolidin-1-yl]methanone Chemical compound CN(C)C1CN(CC1O)C(=O)c1cccc(Oc2cc(CN)cc(n2)C(F)(F)F)c1 JWSIZPAOIFLWKM-UHFFFAOYSA-N 0.000 description 1
- FFRROXAYQLTMOP-UHFFFAOYSA-N [3-[4-(aminomethyl)pyridin-2-yl]oxyphenyl]-[3-hydroxy-3-(trifluoromethyl)pyrrolidin-1-yl]methanone Chemical compound NCC1=CC(=NC=C1)OC=1C=C(C=CC=1)C(=O)N1CC(CC1)(C(F)(F)F)O FFRROXAYQLTMOP-UHFFFAOYSA-N 0.000 description 1
- KUHWOXZLDIRTOV-UHFFFAOYSA-N [3-[4-(aminomethyl)pyridin-2-yl]phenyl]-[3-hydroxy-3-(trifluoromethyl)pyrrolidin-1-yl]methanone Chemical compound NCC1=CC(=NC=C1)C=1C=C(C=CC=1)C(=O)N1CC(CC1)(C(F)(F)F)O KUHWOXZLDIRTOV-UHFFFAOYSA-N 0.000 description 1
- KDSYNTPPPISIJB-UHFFFAOYSA-N [3-[[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxymethyl]phenyl]-(3-fluoro-4-hydroxypyrrolidin-1-yl)methanone Chemical compound NCc1cc(OCc2cccc(c2)C(=O)N2CC(O)C(F)C2)nc(c1)C(F)(F)F KDSYNTPPPISIJB-UHFFFAOYSA-N 0.000 description 1
- YIDXXRWJPJLIKX-UHFFFAOYSA-N [4-[4-(aminomethyl)pyridin-2-yl]phenyl]-[3-hydroxy-3-(trifluoromethyl)pyrrolidin-1-yl]methanone Chemical compound NCC1=CC(=NC=C1)C1=CC=C(C=C1)C(=O)N1CC(CC1)(C(F)(F)F)O YIDXXRWJPJLIKX-UHFFFAOYSA-N 0.000 description 1
- FGHFVYQROSXPMY-UHFFFAOYSA-N ethyl 3-[[3-[4-(aminomethyl)pyridin-2-yl]oxybenzoyl]amino]benzoate hydrochloride Chemical compound Cl.CCOC(=O)c1cccc(NC(=O)c2cccc(Oc3cc(CN)ccn3)c2)c1 FGHFVYQROSXPMY-UHFFFAOYSA-N 0.000 description 1
- QRJCVSVAVNMTGZ-UHFFFAOYSA-N methyl 4-[[3-[4-(aminomethyl)pyridin-2-yl]oxybenzoyl]amino]benzoate hydrochloride Chemical compound Cl.COC(=O)c1ccc(NC(=O)c2cccc(Oc3cc(CN)ccn3)c2)cc1 QRJCVSVAVNMTGZ-UHFFFAOYSA-N 0.000 description 1
- KJLLUPUBVGFYQW-UHFFFAOYSA-N methyl 4-[[[3-[4-(aminomethyl)pyridin-2-yl]oxybenzoyl]amino]methyl]benzoate hydrochloride Chemical compound Cl.COC(=O)c1ccc(CNC(=O)c2cccc(Oc3cc(CN)ccn3)c2)cc1 KJLLUPUBVGFYQW-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562129531P | 2015-03-06 | 2015-03-06 | |
| US62/129,531 | 2015-03-06 | ||
| PCT/US2016/020731 WO2016144702A1 (en) | 2015-03-06 | 2016-03-03 | Lysyl oxidase-like 2 inhibitors and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018510852A JP2018510852A (ja) | 2018-04-19 |
| JP2018510852A5 true JP2018510852A5 (cg-RX-API-DMAC7.html) | 2020-07-16 |
| JP6800872B2 JP6800872B2 (ja) | 2020-12-16 |
Family
ID=56878985
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017545627A Expired - Fee Related JP6800872B2 (ja) | 2015-03-06 | 2016-03-03 | リシルオキシダーゼ様２阻害剤とその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US10766860B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3265445B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6800872B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN107624110B (cg-RX-API-DMAC7.html) |
| ES (1) | ES2872553T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2016144702A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2872553T3 (es) | 2015-03-06 | 2021-11-02 | Pharmakea Inc | Inhibidores de lisil oxidasa tipo-2 y usos de los mismos |
| KR102594441B1 (ko) | 2015-03-06 | 2023-10-25 | 파마케아, 인크. | 플루오르화된 리실 옥시다아제-유사 2 억제제 및 이의 용도 |
| WO2017139274A1 (en) | 2016-02-09 | 2017-08-17 | Pharmakea, Inc. | Quinolinone lysyl oxidase-like 2 inhibitors and uses thereof |
| GB201602934D0 (en) | 2016-02-19 | 2016-04-06 | Cancer Res Inst Royal | Compounds |
| US10774069B2 (en) | 2016-09-07 | 2020-09-15 | Pharmakea, Inc. | Crystalline forms of a lysyl oxidase-like 2 inhibitor and methods of making |
| BR112019004513A2 (pt) | 2016-09-07 | 2019-06-18 | Pharmakea Inc | usos de um inibidor de lisil oxidase-like 2 |
| AU2017322427B2 (en) | 2016-09-09 | 2021-12-23 | Incyte Corporation | Pyrazolopyridine derivatives as HPK1 modulators and uses thereof for the treatment of cancer |
| WO2018049191A1 (en) | 2016-09-09 | 2018-03-15 | Incyte Corporation | Pyrazolopyridone derivatives as hpk1 modulators and uses thereof for the treatment of cancer |
| US20180072718A1 (en) | 2016-09-09 | 2018-03-15 | Incyte Corporation | Pyrazolopyridine compounds and uses thereof |
| WO2018049152A1 (en) | 2016-09-09 | 2018-03-15 | Incyte Corporation | Pyrazolopyrimidine derivatives as hpk1 modulators and uses thereof for the treatment of cancer |
| WO2018152220A1 (en) | 2017-02-15 | 2018-08-23 | Incyte Corporation | Pyrazolopyridine compounds and uses thereof |
| WO2019051199A1 (en) | 2017-09-08 | 2019-03-14 | Incyte Corporation | 6-CYANO-INDAZOLE COMPOUNDS AS HEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) MODULATORS |
| US10745388B2 (en) | 2018-02-20 | 2020-08-18 | Incyte Corporation | Indazole compounds and uses thereof |
| EP3755703B1 (en) | 2018-02-20 | 2022-05-04 | Incyte Corporation | N-(phenyl)-2-(phenyl)pyrimidine-4-carboxamide derivatives and related compounds as hpk1 inhibitors for treating cancer |
| WO2019164847A1 (en) | 2018-02-20 | 2019-08-29 | Incyte Corporation | Indazole compounds and uses thereof |
| RS63124B1 (sr) | 2018-03-08 | 2022-05-31 | Incyte Corp | Aminopirazin diol jedinjenja kao pi3k-y inhibitori |
| US11299473B2 (en) | 2018-04-13 | 2022-04-12 | Incyte Corporation | Benzimidazole and indole compounds and uses thereof |
| BR112020022961A2 (pt) * | 2018-05-11 | 2021-02-17 | Glaxosmithkline Intellectual Property Development Limited | inibidores de furina |
| GB201809295D0 (en) | 2018-06-06 | 2018-07-25 | Institute Of Cancer Res Royal Cancer Hospital | Lox inhibitors |
| WO2020010003A1 (en) | 2018-07-02 | 2020-01-09 | Incyte Corporation | AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS |
| WO2020024017A1 (en) | 2018-08-03 | 2020-02-06 | Pharmaxis Ltd. | Haloallylamine sulfone derivative inhibitors of lysyl oxidases and uses thereof |
| US10899755B2 (en) | 2018-08-08 | 2021-01-26 | Incyte Corporation | Benzothiazole compounds and uses thereof |
| TW202028207A (zh) | 2018-09-25 | 2020-08-01 | 美商英塞特公司 | 吡唑并嘧啶化合物及其用途 |
| GB201818750D0 (en) | 2018-11-16 | 2019-01-02 | Institute Of Cancer Res Royal Cancer Hospital | Lox inhibitors |
| AU2019387370A1 (en) | 2018-11-30 | 2021-06-10 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
| US11430112B2 (en) * | 2019-05-24 | 2022-08-30 | PharmaNest LLC | Systems and methods for quantitative phenotyping of fibrosis |
| BR112022000325A2 (pt) | 2019-07-11 | 2022-03-15 | Escape Bio Inc | Indazois e azaindazois como inibidores de lrrk2 |
| KR20220059480A (ko) | 2019-08-06 | 2022-05-10 | 인사이트 코포레이션 | 고체 형태의 hpk1 억제제 |
| WO2021053234A1 (en) * | 2019-09-19 | 2021-03-25 | Johann Wolfgang Goethe-Universität Frankfurt am Main | Compounds and compositions for treating kidney disease |
| EP4138824A4 (en) * | 2020-04-21 | 2024-05-01 | Anovia Biosciences, Inc. | METHODS AND COMPOSITIONS FOR INHIBITING LOX ENZYME |
| US12233056B2 (en) | 2022-04-06 | 2025-02-25 | Syntara Limited | Lysyl oxidase inhibitors for treating myeloid malignancies |
| GB202209624D0 (en) | 2022-06-30 | 2022-08-17 | Institute Of Cancer Res Royal Cancer Hospital | Prodrugs |
| GB202209622D0 (en) | 2022-06-30 | 2022-08-17 | Institute Of Cancer Res Royal Cancer Hospital | Compounds |
Family Cites Families (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1057009A (en) | 1912-11-07 | 1913-03-25 | Lewis T Rhoades | Spark-producing mechanism for internal-combustion engines. |
| IE56702B1 (en) | 1982-12-01 | 1991-11-06 | Usv Pharma Corp | Antiinflammatory antiallergic compounds |
| US5021456A (en) | 1988-02-25 | 1991-06-04 | Merrell Dow Pharmaceuticals Inc. | Inhibitors of lysyl oxidase |
| US5250532A (en) | 1991-04-11 | 1993-10-05 | Dowelanco | 3,4,N-trisubstituted-4,5-dihydro-1H-pyrazole-1-carboxamides and their use as insecticides |
| US5563143A (en) | 1994-09-21 | 1996-10-08 | Pfizer Inc. | Catechol diether compounds as inhibitors of TNF release |
| US5691364A (en) * | 1995-03-10 | 1997-11-25 | Berlex Laboratories, Inc. | Benzamidine derivatives and their use as anti-coagulants |
| US7125880B1 (en) | 1995-06-06 | 2006-10-24 | Pfizer Inc. | Corticotropin releasing factor antagonists |
| US6956047B1 (en) | 1995-06-06 | 2005-10-18 | Pfizer Inc. | Corticotropin releasing factor antagonists |
| US6632823B1 (en) | 1997-12-22 | 2003-10-14 | Merck & Co., Inc. | Substituted pyridine compounds useful as modulators of acetylcholine receptors |
| PL357589A1 (en) | 2000-01-18 | 2004-07-26 | Pfizer Products Inc. | Corticotropin releasing factor antagonists |
| US20020147198A1 (en) | 2001-01-12 | 2002-10-10 | Guoqing Chen | Substituted arylamine derivatives and methods of use |
| US6878714B2 (en) | 2001-01-12 | 2005-04-12 | Amgen Inc. | Substituted alkylamine derivatives and methods of use |
| US7102009B2 (en) | 2001-01-12 | 2006-09-05 | Amgen Inc. | Substituted amine derivatives and methods of use |
| US7105682B2 (en) | 2001-01-12 | 2006-09-12 | Amgen Inc. | Substituted amine derivatives and methods of use |
| US6995162B2 (en) | 2001-01-12 | 2006-02-07 | Amgen Inc. | Substituted alkylamine derivatives and methods of use |
| US20030134836A1 (en) | 2001-01-12 | 2003-07-17 | Amgen Inc. | Substituted arylamine derivatives and methods of use |
| AUPR688101A0 (en) * | 2001-08-08 | 2001-08-30 | Luminis Pty Limited | Protein domains and their ligands |
| TWI319387B (en) | 2002-04-05 | 2010-01-11 | Astrazeneca Ab | Benzamide derivatives |
| US7307088B2 (en) | 2002-07-09 | 2007-12-11 | Amgen Inc. | Substituted anthranilic amide derivatives and methods of use |
| FI20030030A0 (fi) | 2003-01-09 | 2003-01-09 | Orion Corp | Uusia yhdisteitä |
| JP2007519705A (ja) | 2004-01-29 | 2007-07-19 | ファイザー・プロダクツ・インク | Ｃｎｓ障害を治療するための非定型抗精神病薬とアミノメチルピリジルオキシメチル／ベンゾイソオキサゾールアザビシクロ誘導体の組合せ |
| CA2558568A1 (en) | 2004-03-12 | 2005-09-29 | Eli Lilly And Company | Opioid receptor antagonists |
| US7378448B2 (en) | 2004-03-15 | 2008-05-27 | Eli Lilly And Company | Diphenylether amide derivatives as opioid receptor antagonists |
| AU2005238386A1 (en) | 2004-04-30 | 2005-11-10 | Takeda Pharmaceutical Company Limited | Heterocyclic amide compound and use thereof as an MMP-13 inhibitor |
| US7507748B2 (en) | 2004-07-22 | 2009-03-24 | Amgen Inc. | Substituted aryl-amine derivatives and methods of use |
| US20070270430A1 (en) | 2004-09-10 | 2007-11-22 | Pfzer Inc | Methods of Treating Cognitive Disorders Using Pyridyloxymethyl and Benzisoxazole Azabicyclic Derivatives |
| EP1791541A2 (en) | 2004-09-10 | 2007-06-06 | Pfizer Products Inc. | Methods of treating mood disorders using benzisoxazole containing diazabicyclic compounds |
| EP1807417A2 (en) | 2004-11-04 | 2007-07-18 | Neurogen Corporation | Pyrazolylmethyl heteroaryl derivatives |
| DE102004056226A1 (de) | 2004-11-22 | 2006-05-24 | Burchardt, Elmar Reinhold, Dr.Dr. | Neuartige Inhibitoren der Lysyloxidase |
| ATE440091T1 (de) | 2005-01-31 | 2009-09-15 | Merck & Co Inc | Antidiabetische bicyclische verbindungen |
| GB0614579D0 (en) | 2006-07-21 | 2006-08-30 | Black James Foundation | Pyrimidine derivatives |
| EP2121703A4 (en) | 2006-08-18 | 2011-12-28 | Astrazeneca Ab | THIENOPYRIMIDIN-4-ON- AND THIENOPYRIDAZIN-7-ONDERIVATES AS MCH-RL ANTAGONISTS |
| IL184627A0 (en) | 2007-07-15 | 2008-12-29 | Technion Res & Dev Foundation | Agents for diagnosing and modulating metastasis and fibrosis as well as inflammation in a mammalian tissue |
| WO2009035791A1 (en) | 2007-08-02 | 2009-03-19 | Arresto Biosciences | Lox and l0xl2 inhibitors and uses thereof |
| RU2012107163A (ru) | 2009-07-28 | 2013-09-10 | Анакор Фармасьютикалз, Инк. | Тризамещенные борсодержащие молекулы |
| JP2013518909A (ja) * | 2010-02-08 | 2013-05-23 | キナゲン，インク． | アロステリックキナーゼ阻害が関係する治療方法および組成物 |
| JP5816635B2 (ja) | 2010-03-05 | 2015-11-18 | カリオファーム セラピューティクス，インコーポレイテッド | 核輸送調節剤およびその使用 |
| WO2011150201A2 (en) * | 2010-05-27 | 2011-12-01 | Ambit Biosciences Corporation | Azolyl amide compounds and methods of use thereof |
| EP2441755A1 (en) * | 2010-09-30 | 2012-04-18 | Almirall, S.A. | Pyridine- and isoquinoline-derivatives as Syk and JAK kinase inhibitors |
| CA2818542A1 (en) | 2010-11-19 | 2012-05-24 | Incyte Corporation | Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors |
| TW201313721A (zh) | 2011-08-18 | 2013-04-01 | Incyte Corp | 作為ｊａｋ抑制劑之環己基氮雜環丁烷衍生物 |
| ES2627347T3 (es) | 2011-10-20 | 2017-07-27 | Glaxosmithkline Llc | Aza-heterociclos bicíclicos sustituidos y análogos como moduladores de sirtuina |
| EP2841421B1 (en) | 2012-04-25 | 2019-06-05 | RaQualia Pharma Inc | Amide derivatives as ttx-s blockers |
| JP2016500700A (ja) | 2012-10-30 | 2016-01-14 | ギリアード サイエンシーズ， インコーポレイテッド | リシルオキシダーゼ様２（ｌｏｘｌ２）に関する治療および診断方法 |
| CN104854086B (zh) | 2012-12-18 | 2017-06-27 | Ea制药株式会社 | 杂环酰胺衍生物和含有其的药物 |
| JP2018522812A (ja) | 2014-08-05 | 2018-08-16 | ザ ユニヴァーシティ オブ ブリティッシュ コロンビア | カスパーゼ−６のモジュレーター |
| PT3256463T (pt) | 2015-02-15 | 2019-12-05 | Hoffmann La Roche | Derivados de 1-(het)arilsulfonil-(pirrolidina ou piperidina)-2-carboxamida e a sua utilização como antagonistas do trpa1 |
| ES2872553T3 (es) | 2015-03-06 | 2021-11-02 | Pharmakea Inc | Inhibidores de lisil oxidasa tipo-2 y usos de los mismos |
| KR102594441B1 (ko) | 2015-03-06 | 2023-10-25 | 파마케아, 인크. | 플루오르화된 리실 옥시다아제-유사 2 억제제 및 이의 용도 |
| JP2018519292A (ja) * | 2015-07-01 | 2018-07-19 | ファーマケア，インク． | リシルオキシダーゼ様２阻害剤およびその使用 |
| WO2017139274A1 (en) * | 2016-02-09 | 2017-08-17 | Pharmakea, Inc. | Quinolinone lysyl oxidase-like 2 inhibitors and uses thereof |
| US10774069B2 (en) * | 2016-09-07 | 2020-09-15 | Pharmakea, Inc. | Crystalline forms of a lysyl oxidase-like 2 inhibitor and methods of making |
| BR112019004513A2 (pt) * | 2016-09-07 | 2019-06-18 | Pharmakea Inc | usos de um inibidor de lisil oxidase-like 2 |
-
2016
- 2016-03-03 ES ES16762185T patent/ES2872553T3/es active Active
- 2016-03-03 US US15/555,785 patent/US10766860B2/en not_active Expired - Fee Related
- 2016-03-03 CN CN201680026238.9A patent/CN107624110B/zh not_active Expired - Fee Related
- 2016-03-03 WO PCT/US2016/020731 patent/WO2016144702A1/en not_active Ceased
- 2016-03-03 JP JP2017545627A patent/JP6800872B2/ja not_active Expired - Fee Related
- 2016-03-03 EP EP16762185.3A patent/EP3265445B1/en active Active
-
2020
- 2020-07-17 US US16/932,617 patent/US11358936B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018510852A5 (cg-RX-API-DMAC7.html) | ||
| RU2374230C2 (ru) | Фенильные производные в качестве ppar агонистов | |
| RU2328494C2 (ru) | Замещенные пиперазины, (1,4)-диазепины и 2,5-диазабицикло[2.2.1]гептаны в качестве н1-и/или н3-антагонистов гистамина или обратных н3-антагонистов гистамина | |
| RU2003102612A (ru) | N-окиси в качестве пролекарств производных 4-фенилпиридина, являющихся натагонистами рецептора nk-1 | |
| JP2009529047A5 (cg-RX-API-DMAC7.html) | ||
| JP2007519694A5 (cg-RX-API-DMAC7.html) | ||
| JP2015517981A5 (cg-RX-API-DMAC7.html) | ||
| JP2005509622A5 (cg-RX-API-DMAC7.html) | ||
| FI4055021T3 (fi) | Heterosyklisiä rip1:tä estäviä yhdisteitä | |
| JP2005501120A5 (cg-RX-API-DMAC7.html) | ||
| JP2005505618A5 (cg-RX-API-DMAC7.html) | ||
| RU2007101239A (ru) | Антагонисты рецептора вазопрессина v-1а | |
| CN1342162A (zh) | 取代的2－芳基－3－(杂芳基)－咪唑并[1,2－a]嘧啶类化合物以及相关的药物组合物和方法 | |
| JP2005535586A5 (cg-RX-API-DMAC7.html) | ||
| JP2004517087A5 (cg-RX-API-DMAC7.html) | ||
| RU2002121645A (ru) | Производные 2-аминоникотинамида и их применение в качестве ингибиторов vegf-рецептора тирозинкиназы | |
| IL276946B (en) | Antiproliferative compounds and methods of use thereof | |
| JP2007504160A5 (cg-RX-API-DMAC7.html) | ||
| RU2002127781A (ru) | Производные карбоновых кислот в качестве антагонистов ip | |
| JP2004517049A5 (cg-RX-API-DMAC7.html) | ||
| RU2005136355A (ru) | Производные сульфонамида, их получение и применение в качестве лекарственных средств | |
| JP2018168191A5 (cg-RX-API-DMAC7.html) | ||
| JP2009533323A5 (cg-RX-API-DMAC7.html) | ||
| JP2005524609A5 (cg-RX-API-DMAC7.html) | ||
| JP2007502815A5 (cg-RX-API-DMAC7.html) |